EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access

A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest

Keith Couper, Chen Ji, Charles D Deakin, Rachael T Fothergill, Jerry P Nolan, John B Long, James M Mason, Felix Michelet, Chloe Norman, Henry Nwankwo, Tom Quinn, Anne-Marie Slowther und 35 weitere

New England Journal of Medicine · 23.01.2025 · 392 (4) · 336-348

DOI: 10.1056/nejmoa2407780 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 23.01.2025. Verfasst von Keith Couper und 46 weiteren Autor:innen. Beteiligte Einrichtung: From the Warwick Medical School, Clinical Trials Unit, University of Warwick (K.C., C.J., J.P.N., J.B.L., J.M.M., F.M., C.N., H.N., A.-M.S., M.A.S., …. Hauptthemen laut MEDLINE: Epinephrine, Out-of-Hospital Cardiac Arrest. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Health, Health Technology Assessment Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In patients with out-of-hospital cardiac arrest, the effectiveness of drugs such as epinephrine is highly time-dependent. An intraosseous route of drug administration may enable more rapid drug administration than an intravenous route; however, its effect on clinical outcomes is uncertain. METHODS: We conducted a multicenter, open-label, randomized trial across 11 emergency medical systems in the United Kingdom that involved adults in cardiac arrest for whom vascular access for drug administration was needed. Patients were randomly assigned to receive treatment from paramedics by means of an intraosseous-first or intravenous-first vascular access strategy. The primary outcome was survival at 30 days. Key secondary outcomes included any return of spontaneous circulation and favorable neurologic function at hospital discharge (defined by a score of 3 or less on the modified Rankin scale, on which scores range from 0 to 6, with higher scores indicating greater disability). No adjustment for multiplicity was made. RESULTS: A total of 6082 patients were assigned to a trial group: 3040 to the intraosseous group and 3042 to the intravenous group. At 30 days, 137 of 3030 patients (4.5%) in the intraosseous group and 155 of 3034 (5.1%) in the intravenous group were alive (adjusted odds ratio, 0.94; 95% confidence interval [CI], 0.68 to 1.32; P = 0.74). At the time of hospital discharge, a favorable neurologic outcome was observed in 80 of 2994 patients (2.7%) in the intraosseous group and in 85 of 2986 (2.8%) in the intravenous group (adjusted odds ratio, 0.91; 95% CI, 0.57 to 1.47); a return of spontaneous circulation at any time occurred in 1092 of 3031 patients (36.0%) and in 1186 of 3035 patients (39.1%), respectively (adjusted odds ratio, 0.86; 95% CI, 0.76 to 0.97). During the trial, one adverse event, which occurred in the intraosseous group, was reported. CONCLUSIONS: Among adults with out-of-hospital cardiac arrest requiring drug therapy, the use of an intraosseous-first vascular access strategy did not result in higher 30-day survival than an intravenous-first strategy. (Funded by the National Institute for Health and Care Research; PARAMEDIC-3 ISRCTN Registry number, ISRCTN14223494.).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpinephrineOut-of-Hospital Cardiac ArrestAgedFemaleHumansMaleMiddle AgedEmergency Medical ServicesInfusions, IntraosseousReturn of Spontaneous CirculationUnited KingdomInjections, IntravenousAged, 80 and overTreatment OutcomeKaplan-Meier Estimate

Substanzen

Epinephrine

Autor:innen und Institutionen

  • From the Warwick Medical School, Clinical Trials Unit, University of Warwick (K.C., C.J., J.P.N., J.B.L., J.M.M., F.M., C.N., H.N., A.-M.S., M.A.S., K.R.S., S.W., R.L., G.D.P.), and the Critical Care Unit, University Ho…

ORCID-Profile: Adam Mellett-Smith

Förderung

  • Department of Health
  • Health Technology Assessment Programme

Zitieren

APA

Couper, K., Ji, C., Deakin, C. D., Fothergill, R. T., Nolan, J. P., Long, J. B., Mason, J. M., Michelet, F., Norman, C., Nwankwo, H., Quinn, T., Slowther, A. M., Smyth, M. A., Starr, K. R., Walker, A., Wood, S., Bell, S., Bradley, G., Brown, M., …, & PARAMEDIC-3 Collaborators (2025). A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest. New England Journal of Medicine, 392(4), 336-348. https://doi.org/10.1056/nejmoa2407780

Vancouver

Couper K, Ji C, Deakin CD, Fothergill RT, Nolan JP, Long JB, et al. A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest. New England Journal of Medicine. 2025;392(4):336-348. doi:10.1056/nejmoa2407780

BibTeX
@article{Couper2025,
  author = {Couper, Keith and Ji, Chen and Deakin, Charles D and Fothergill, Rachael T and Nolan, Jerry P and Long, John B and Mason, James M and Michelet, Felix and Norman, Chloe and Nwankwo, Henry and Quinn, Tom and Slowther, Anne-Marie and Smyth, Michael A and Starr, Kath R and Walker, Alison and Wood, Sara and Bell, Steve and Bradley, Gemma and Brown, Martina and Brown, Shona and Burrow, Emma and Charlton, Karl and Claxton Dip, Andrew and Dra'gon, Victoria and Evans, Christine and Falloon, Jakob and Foster, Theresa and Kearney, Justin and Lang, Nigel and Limmer, Matthew and Mellett-Smith, Adam and Miller, Joshua and Mills, Carla and Osborne, Ria and Rees, Nigel and Spaight, Robert E S and Squires, Gemma L and Tibbetts, Belinda and Waddington, Michelle and Whitley, Gregory A and Wiles, Jason V and Williams, Julia and Wiltshire, Sarah and Wright, Adam and Lall, Ranjit and Perkins, Gavin D and PARAMEDIC-3 Collaborators, PARAMEDIC-3 Collaborators},
  title = {A Randomized Trial of Drug Route in Out-of-Hospital Cardiac Arrest},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {392},
  number = {4},
  pages = {336--348},
  doi = {10.1056/nejmoa2407780}
}
Kostenlos starten →